Exercise and Beetroot Juice for Peripheral Artery Disease
(RESIST Trial)
Trial Summary
What is the purpose of this trial?
RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether exercise "responders" have greater Δ nitrite increases compared to "non-responders"; 3) among non-responders, whether supplementing exercise with nitrate-rich beetroot juice between weeks 13-24 increases Δ nitrite and improves 6-minute walk at 24-week follow-up.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must stop consuming beetroot juice, oral nitrate or nitrite, and beetroot supplements for 30 days before the trial and throughout the study.
What data supports the effectiveness of the treatment Nitrate-Rich Beetroot Juice + supervised exercise therapy for Peripheral Artery Disease?
Research shows that supervised exercise therapy (SET) improves walking ability in people with peripheral artery disease (PAD), and supervised treadmill-walking training enhances walking capacity and calf-muscle strength. These findings suggest that combining exercise with treatments like beetroot juice, which is known for its potential cardiovascular benefits, could be effective for PAD.12345
Is supervised exercise therapy safe for people with peripheral artery disease?
How is supervised treadmill exercise different from other treatments for peripheral artery disease?
Supervised treadmill exercise (SET) is unique because it specifically focuses on improving walking capacity and calf muscle strength through guided walking sessions, which is different from other treatments like home-based exercise or surgical options. It involves regular, structured exercise sessions under professional supervision, which can enhance endurance and quality of life for patients with peripheral artery disease.1451011
Research Team
Eligibility Criteria
This trial is for individuals with Peripheral Arterial Disease (PAD), specifically those who experience intermittent claudication, which is muscle pain during exercise due to poor blood flow. Participants should be able to perform treadmill exercises and have not been involved in regular exercise programs recently.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week supervised treadmill exercise program or attend educational sessions
Supplementation
Non-responders receive an additional 12 weeks of exercise with either nitrate-rich or placebo beetroot juice
Follow-up
Participants are monitored for changes in six-minute walk distance and other biomarkers
Treatment Details
Interventions
- Nitrate-Rich Beetroot Juice + supervised exercise therapy (Combination Product)
- Placebo + supervised exercise therapy (Combination Product)
- Supervised Treadmill Exercise (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School